Register for our free email digests:
Lonza Group AG
http://www.lonza.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Lonza Group AG
Coronavirus Update: BioNTech Gets €375m From Germany To Fund Vaccine
Plus: Valneva confirms supply deal with the UK government for its inactivated vaccine candidate; Humanigen expands manufacturing ahead of Phase III data.
Video Panel: How China Inc. Sells Latest Therapies In An Untapped Market
During the “Road to Commercialization” panel session during EBD/Informa Connect's recent annual ChinaBio partnering event, senior executives from top Chinese biotechs along with a leading contract manufacturing organization and venture fund shared views on biologics commercialization in China. Partnerships to accelerate the process, as well as the future commercial direction of novel biologics in their fastest-growing market worldwide, were also discussed.
Fujifilm Medical Targets IVD Market With Business Reshuffle
The integration of Fujifilm Wako Diagnostics USA adds in vitro diagnostic reagents and biomarkers to Fujifilm Medical System's portfolio of diagnostic solutions.
Samsung BioLogics’ 'Super Plant' Reflects Robust Global COVID-19 R&D
Samsung BioLogics’ construction of a fourth, large-scale manufacturing plant reflects increasing orders amid robust global COVID-19 R&D activities and further cements the Korean firm's position as the world's biggest contract biologics producer.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
- Diversified
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
- Services
- Contract Manufacturing Organization
-
Biotechnology
- Drug Discovery Tools
- Other Names / Subsidiaries
-
- Algonomics NV
- Capsugel S.A.
- HansaBioMed Life Sciences OÜ
- InterHealth Nutraceuticals, Inc.
- Lonza Group Ltd.
- MODA Technology
- Micro-Macinazione S.A.
- PharmaCell B.V.